Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essential Amino Acid Supplementation Following Total Knee Arthroplasty
NCT02926235Phase 4Terminated
- Sponsor
- Hospital for Special Surgery
- Start
- Apr 2016
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of essential amino acids-University of Oregon in muscle atrophy (2 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Change in Quadriceps Strength at 6 weeks. Started Apr 2016; status: terminated.
02
Drugs
essential amino acids-University of Oregon
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT02926235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02926235.